Dhavalkumar Dhirajlal Patel insider trades
Open-market stock purchases and sales by Dhavalkumar Dhirajlal Patel, EVP, Chief Scientific Officer at Sana Biotechnology, Inc, from SEC Form 4 filings since Aug 26, 2026.
Companies traded
- SANA Sana Biotechnology, Inc: other filings, last Aug 27, 2026
Get free alerts when Dhavalkumar Dhirajlal Patel files a new trade →